Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients

Song Y Park; Candice Church; Nora A Alexander; Michi M Shinohara; Kelly G Paulson; Karl D Lewis; Nancy S Lee; Paul Nghiem

doi:10.1016/j.jdcr.2020.11.020

Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients

JAAD Case Rep. 2020 Dec 1:8:28-33. doi: 10.1016/j.jdcr.2020.11.020. eCollection 2021 Feb.

Authors

Song Y Park¹, Candice Church¹, Nora A Alexander¹, Michi M Shinohara¹, Kelly G Paulson², Karl D Lewis³, Nancy S Lee⁴, Paul Nghiem¹

Affiliations

¹ University of Washington, Seattle, Washington.
² Swedish Cancer Institute, Seattle/Edmonds, Washington.
³ University of Colorado Cancer Center, Aurora, Colorado.
⁴ Kaiser Permanente, Hematology and Oncology, San Diego, California.

No abstract available

Keywords: AIDS; CR, complete response; HIV; ICI, immune checkpoint inhibitors; IHC, immunohistochemistry; MCC; MCC, Merkel cell carcinoma; MCPyV, Merkel cell polyomavirus; Merkel cell carcinoma; PD-1, anti-programmed cell death-1; PD-L1, anti-programmed death ligand-1; PET, positron emission tomography; RT, radiation treatment; aMCC, advanced Merkel cell carcinoma; anti-PD-(L)1 agent; immunotherapy.

Publication types

Case Reports

Publication types

Grants and funding